Four-month baldness treatment ruxolitinib helps patients regrow a full head of hair
Three quarters of sufferers of alopecia areata reported significant hair regrowth when taking ruxolitinib, researchers from the Columbia University Medical Center, New York, found. (Source: the Mail online | Health)
Source: the Mail online | Health - September 26, 2016 Category: Consumer Health News Source Type: news
Medical News Today: Alopecia: Hair growth restored with new drug
Clinical trials conducted by Columbia University Medical Center find that JAK inhibitors may trigger hair regrowth in people with alopecia areata. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 26, 2016 Category: Consumer Health News Tags: Dermatology Source Type: news
Drug restores hair growth in patients with alopecia areata
Seventy-five percent of patients with moderate to severe alopecia areata - an autoimmune disease that causes patchy and, less frequently, total hair loss - had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center (CUMC). By the end of treatment, average hair regrowth among the patients was 92 percent. Findings from an open-label clinical trial of 12 patients with alopecia areata were published in the Journal of Clinical Investigation/Insight, (Source: World Pharma News)
Source: World Pharma News - September 23, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Arthritis Drug May Help With Type of Hair Loss
Researchers saw regrowth in patients with the autoimmune disease alopecia areata (Source: WebMD Health)
Source: WebMD Health - September 22, 2016 Category: Consumer Health News Source Type: news
Drug restores hair growth in patients with alopecia areata
Seventy-five percent of patients with an autoimmune disease that causes hair loss had significant hair regrowth after treatment with ruxolitinib, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 22, 2016 Category: Science Source Type: news
Arthritis Drug May Help With Type of Hair Loss
THURSDAY, Sept. 22, 2016 -- For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.
Alopecia areata is an autoimmune disease that causes... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 22, 2016 Category: Journals (General) Source Type: news
Perth model with Alopecia areata shares video of herself without a wig
Lara Kitchen, a 20-year-old model from Perth, was diagnosed with Alopecia areata at 14. She has shared a video of herself without a wig to encourage women to embrace themselves. (Source: the Mail online | Health)
Source: the Mail online | Health - September 9, 2016 Category: Consumer Health News Source Type: news
Tofacitinib clears pediatric alopecia areata in small study
MINNEAPOLIS – The first study to evaluate tofacitinib’s effectiveness at treating severe alopecia areata in the pediatric population found that the janus kinase inhibitor was effective for more than half of the patients, and well tolerated by all.
Of a case series of 13 pediatric patients who had... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 13, 2016 Category: Dermatology Source Type: news
[Podcast] Science Signaling Podcast for 2 August 2016: Patient-specific protein complexes
A technique for identifying patient-specific protein complexes reveals altered signaling in T cells from patients with the autoimmune disease alopecia areata. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - August 3, 2016 Category: Science Authors: Adam G. Schrum Steven C. Neier, Annalisa M. VanHook Source Type: news
Keys to alopecia areata might lie in gut microbiome
SCOTTSDALE, ARIZ. – Wiping out the gut microbiome with antibiotics prevented alopecia areata in a study of mice, providing evidence that the gut microbiome may play a role in alopecia, Dr. James Chen reported at the annual meeting of the Society for Investigative Dermatology.
The finding shows... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 8, 2016 Category: Dermatology Source Type: news
JAK inhibitor improves alopecia, with caveats
SCOTTSDALE, ARIZ. – The Janus kinase (JAK) inhibitor tofacitinib dramatically improved several cases of alopecia areata (AA), although some patients relapsed to worse than baseline after completing treatment in a small open label pilot trial.
“Regrowth was demonstrated in 11 out of 12 patients on... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 8, 2016 Category: Dermatology Source Type: news
Concert Pharmaceuticals begins Phase l trial of CTP-543 to treat alopecia areata
Clinical stage, biopharmaceutical company Concert Pharmaceuticals has begun a Phase l clinical trial of CTP-543 to treat alopecia areata, an autoimmune disease that results in partial or complete loss of hair on the scalp. (Source: Drug Development Technology)
Source: Drug Development Technology - May 19, 2016 Category: Pharmaceuticals Source Type: news
The Humanity of Science
I know a few things about the responsibility of being a mom to a powerhouse of a daughter who just does not like the word "no." Lola is 11 years old and I suspect world domination will be in her future as well as an alphabetized kitchen cabinet for me and my shoes lined up to within an inch of their life. She is the magic in the mix to all who love her, and aside from being a true force of nature, Lola is also a warrior who battled aggressive Alopecia Areata for over for two years. As we watched her beautiful chestnut hair fall out in clumps on the bathroom floor, she remained focused on the sun in the sky and her strawber...
Source: Science - The Huffington Post - May 16, 2016 Category: Science Source Type: news
Fayetteville Company Raising Funds for Hair Loss Treatment
A Fayetteville company is trying to raise $7 million to treat hair loss.
BiologicsMD Inc. raised $400,000 so far, according to its Feb. 8 filing at the U.S Securities & Exchange Commission.
The money raised will go toward helping to get regulatory approval of its treatment for hair loss, mainly for people who have alopecia areata, an autoimmune skin disease that causes hair loss on the head and on other parts of the body, said Dr. Rob Gensure, the company’s medical officer.
“They have an immune system problem where their immune system attacks their hair follicle, and it falls out in patches at random times,...
Source: Arkansas Business - Health Care - March 7, 2016 Category: American Health Source Type: news
Targeted Treatment May Reverse Alopecia AreataTargeted Treatment May Reverse Alopecia Areata
The psoriasis drug ustekinumab can spur hair regrowth and normalize immune function in patients with alopecia areata, according to the results of a study in three patients. Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 14, 2015 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
